Table S1.
Panning data for the selection of scFv antibodies against hERG PAS domain
| Panning cycle no. | Solution-phase selection | Solid-phase selection: PAS | |||
| GSTPAS_1 | GST_1 | GSTPAS_2 | GST_2 | ||
| 1 | |||||
| Eluted phage (% of input) | 0.333000 | 0.181000 | 0.000034 | ||
| Enrichment* | n.d. | n.d. | 1 | ||
| 2 | |||||
| Eluted phage (% of input) | 0.000094 | 0.000128 | 0.004400 | ||
| Enrichment* | 1 | 1 | 129 | ||
| 3 | |||||
| Eluted phage (% of input) | 0.028 | 0.044 | 0.115 | ||
| Enrichment* | 297.9 | 343.8 | 3,382 | ||
| 4 | |||||
| Eluted phage (% of input) | 0.19300 | 0.00083 | 0.35600 | 0.00131 | 0.09600 |
| Enrichment* | 2,053 | 0.03 | 2,781 | 0.03 | 2,823 |
GSTPAS_1 and GSTPAS_2 were purified as fusion proteins and coupled to magnetic beads for screening. GST_1 and GST_2 were purified as control. PAS protein was purified and coated onto Nunc Maxisorp plates for screening. n.d., not determined.
Enrichment was calculated as the ratio between the eluted phage in a certain cycle and the eluted phage in the first cycle.